← Back

Wire · opportunities

Alert Failures, AI Errors, And Hypoglycemic Episodes: FDA Wants Input On Exempt Health Software

Published

17 July 2026

Topic

opportunities

Sectors

Digital Health

Geography

United States

Source

Read at insights.citeline.com

Verified

Fusion42 · 17 July 2026 · Fusion42 review

The FDA is seeking public input on how to regulate exempt health software, with specific concerns about alert failures, AI errors, and patient safety incidents like hypoglycemic episodes. The agency is attempting to define which software poses genuine risk and therefore should require oversight versus which remains safely exempt.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ The Wire takeaway

If you build health software that doesn't touch diagnosis or treatment, you've been exempt from FDA oversight—but that door is closing. The agency is now writing rules around AI and alerts, which means your unregulated product will soon need either a compliance pathway or a business model pivot.

Coverage

1 source · 17 Jul 2026

Related on Wire

Topics

Digital Healthfda-exemptionai-safetysoftware-regulationhealthtech-compliance